Evaluation of the Three Glucometer Devices Performance in Comparison with the Cobas Integra 400 Plus Autoanalyzer in Measuring Blood Glucose Levels: A Comparative Cross-Sectional Study
Objective: The study aimed to evaluate the performance of the three glucometers compared to standard the laboratory method (Cobas Integra 400 Plus) in measuring blood glucose levels. Patients and Methods: A total of 100 Yemeni diabetic patients were randomly recruited into a comparative cross-sectional study. Venous and finger-pricked blood samples were obtained from all participants and used for blood glucose levels measurement following the standard procedures. Results: The mean blood glucose levels for one-hundred diabetic patients using the Gluco Contour TS and Gluco SD Codefree were not significantly different compared with the Cobas Integra 400 Plus (12.14 ± 6.89 mmol/L vs. 12.85 ± 8.83 mmol/L, P = 0.159; 12.50 ± 7.18 mmol/L vs. 12.85 ± 8.83 mmol/L, P = 0.490), respectively. However, there is a significant difference using the Gluco Alert device from that of the Cobas Integra 400 Plus (11.83 ± 6.94 mmol/L vs. 12.85 ± 8.83 mmol/L, P = 0.046). Furthermore, using the ROC curve at a 95% confidence interval, the Cobas Integra 400 Plus showed a significant agreement with the Gluco Contour TS (51.4%), Gluco SD Codefree (50.4%), and Gluco Alert (39.3%), respectively. For determining accuracy, the sensitivity of the glucometer devices was the following: Gluco SD Codefree (87.3%), Contour TS (85.9%), and Gluco Alert (78.9%). In this regard, the highest specificity was related to Gluco Contour TS (65.5%). Conclusion: The correlation between both methods was good, with high sensitivity and specificity in measuring blood glucose levels as indicated by the ROC curve. Thus, we suggest using these glucometers at homes and hospitals as a point of care for diabetic patients.
References
[1]
American Diabetes Association (2014) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 37, S81-S90. https://doi.org/10.2337/dc14-S081
[2]
Zhang, P., Zhang, X., Brown, J., Vistisen, D., Sicree, R., Shaw, J., et al. (2010) Global Healthcare Expenditure on Diabetes for 2010 and 2030. Diabetes Research and Clinical Practice, 87, 293-301. https://doi.org/10.1016/j.diabres.2010.01.026
[3]
American Diabetes Association (2008) Economic Costs of Diabetes in the US in 2007. Diabetes Care, 31, 596-615. https://doi.org/10.2337/dc08-9017
[4]
Van den Berghe, G., Wouters, P.J., Bouillon, R., Weekers, F., Verwaest, P., Schetz, M., et al. (2003) Outcome Benefit of Intensive Insulin Therapy in the Critically Ill: Insulin Dose Versus Glycemic Control. Critical Care Medicine, 31, 359-366. https://doi.org/10.1097/01.CCM.0000045568.12881.10
[5]
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P.J., Milants, I., et al. (2006) Intensive Insulin Therapy in the Medical ICU. The New England Journal of Medicine, 354, 449-461. https://doi.org/10.1056/NEJMoa052521
[6]
Kalateh Jari, M., Sohrabi, M.B., Khosravi, A. and Zou Alfaghari, P. (2008) Correlation between Blood Glucose Measured Using Glucometers and Standard Laboratory Methods. Iranian Journal of Endocrinology and Metabolism, 10, 277-283.
[7]
Lagarde, W.H., Barrows, F.P., Davenport, M.L., Kang, M., Guess, H.A. and Calikoglu, A.S. (2006) Continuous Subcutaneous Glucose Monitoring in Children with Type 1 Diabetes Mellitus: A Single-Blind, Randomized, Controlled Trial. Pediatric Diabetes, 7, 159-164. https://doi.org/10.1111/j.1399-543X.2006.00162.x
[8]
Scott, M.G. (2010) Glucose Meters: Need for Greater Accuracy (Lab Perspective). In: Joint ADA/AACE Symposium-Point of Care Devices for Glucose and HbA1C: Are They Up to the Task? 70th Annual ADA Scientific Sessions, Orlando, 28 June 2010.
[9]
American Diabetes Association (2016) Standards of Medical Care in Diabetes—2016 Abridged for Primary Care Providers. Clinical Diabetes: A Publication of the American Diabetes Association, 34, 3. https://doi.org/10.2337/diaclin.34.1.3
[10]
Freckmann, G., Baumstark, A., Jendrike, N., Zschornack, E., Kocher, S., Tshiananga, J., et al. (2010) System Accuracy Evaluation of 27 Blood Glucose Monitoring Systems According to DIN EN ISO 15197. Diabetes Technology & Therapeutics, 12, 221-231. https://doi.org/10.1089/dia.2009.0128
[11]
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., et al. (2001) Intensive Insulin Therapy in Critically Ill Patients. New England Journal of Medicine, 345, 1359-1367. https://doi.org/10.1056/NEJMoa011300
[12]
Mann, E.A., Pidcoke, H.F., Salinas, J., Wade, C.E., Holcomb, J.B. and Wolf, S.E. (2007) Accuracy of Glucometers Should Not Be Assumed. American Journal of Critical Care, 16, 531-532. https://doi.org/10.4037/ajcc2007.16.6.531-a
[13]
Mankovsky, B.N. (2011) 4th Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) Applications and Beyond, May 12-14, 2011, Budapest, Hungary. Diabetes Technology & Therapeutics, 13, 1161-1176. https://doi.org/10.1089/dia.2011.0200
[14]
Hortensius, J., Slingerland, R.J., Kleefstra, N., Logtenberg, S.J., Groenier, K.H., Houweling, S.T., et al. (2011) Self-Monitoring of Blood Glucose: The Use of the First or the Second Drop of Blood. Diabetes Care, 34, 556-560. https://doi.org/10.2337/dc10-1694
[15]
Karon, S., Griesmann, L., Scott, R., Bryant, S.C., Dubois, J.A., Shirey, T.L., et al. (2008) Evaluation of the Impact of Haematocrit and Other Interference on the Accuracy of Hospital-Based Glucose Meters. Diabetes Technology & Therapeutics, 10, 111-1120. https://doi.org/10.1089/dia.2007.0257
[16]
Gunaid, A.A. (2002) Prevalence of Known Diabetes and Hypertension in the Republic of Yemen. Eastern Mediterranean Health Journal, 8, 374-385.
[17]
Salacinski, A.J., Alford, M., Drevets, K., Hart, S. and Hunt, B.E. (2014) Validity and Reliability of a Glucometer against Industry Reference Standards. Journal of Diabetes Science and Technology, 8, 95-99. https://doi.org/10.1177/1932296813514315
[18]
Rajendran, R. and Rayman, G. (2014) Point-of-Care Blood Glucose Testing for Diabetes Care in Hospitalized Patients an Evidence-Based Review. Journal of Diabetes Science and Technology, 8, 1081-1090. https://doi.org/10.1177/1932296814538940
[19]
Ginsberg, B.H. (2009) Factors Affecting Blood Glucose Monitoring: Sources of Errors in Measurement. Journal of Diabetes Science and Technology, 3, 903-913. https://doi.org/10.1177/193229680900300438
[20]
Shete, S., Khan, H., Siddiqui, A.M. and Shinde, A. (2016) A Comparative Study of Venous and Capillary Blood Glucose Levels by Semi Autoanalyser and Glucometer. International Journal of Recent Trends in Science and Technology, 1, 46-48.
[21]
Patel, N. and Patel, K. (2015) A Comparative Study of Venous and Capillary Blood Glucose Levels by Different Method. GCSMC Journal of Medical Sciences, 4, 53-56.
[22]
Baig, A., Siddiqui, I., Jabbar, A., Azam, I.S., Sabir, S., Alam, S. and Ghani, F. (2007) Comparison between Bedside Testing of Blood Glucose by Glucometer vs. Centralized Testing in Tertiary Health Care Hospital. Journal of Ayub Medical College Abbottabad, 19, 25-29.
[23]
Kanwugu, O.N., Helegbe, G.K., Aryee, P.A., Akontatiba, N.A, et al. (2017) A Comparative Assessment of the Glucose Monitor (SD Codefree) and Autoanalyzer (BT-3000) in Measuring Blood Glucose among Diabetic Patients. BMC Research Notes, 10, 453. https://doi.org/10.1186/s13104-017-2789-0
[24]
Sudan, K. (2014) Comparison between Glucometer and Chemical Analyzer for Measuring Blood Glucose of Diabetic Patients. International Journal of Current Research, 6, 6610-6613.
[25]
Bimenya, G.S., Nzarubara, G.R., Kiconco, J., Sabuni, S. and Byarugaba, W. (2003) The Accuracy of Self-Monitoring Blood Glucose Meter Systems in Kampala Uganda. African Health Sciences, 3, 23-32.
[26]
Cembrowski, G.S., Tran, D.V., Slater-Maclean, L., Chin, D., Gibney, R.T.N. and Jacka, M. (2010) Could Susceptibility to Low Hematocrit Interference Have Compromised the Results of the NICESUGAR Trial? Clinical Chemistry, 56, 1193-1195. https://doi.org/10.1373/clinchem.2010.146217
[27]
Krouwer, J.S. and Cembrowski, G.S. (2010) A Review of Standards and Statistics Used to Describe Blood Glucose Monitor Performance. Journal of Diabetes Science and Technology, 4, 75-83. https://doi.org/10.1177/193229681000400110
[28]
Corstjens, A.M., Ligtenberg, J.J., van der Horst, I.C., Spanjersberg, R., Lind, J.S., et al. (2006) Accuracy and Feasibility of Point-of-Care and Continuous Blood Glucose Analysis in Critically ill ICU Patients. Critical Care, 10, R135. https://doi.org/10.1186/cc5048
[29]
MostafaGharehbaghi, M. and Ghergherehchi, R. (2016) Comparison of Diagnostic Value of Blood Glucose Meter with that of Laboratory Method in Neonatal Hypoglycemia. Journal of Guilan University of Medical Sciences, 25, 106-112.
